Prevalence of MET exon 14-mutations or MET amplification in non-small cell lung cancer in Swiss patients

被引:0
|
作者
Prince, S. Savic [1 ]
Bihl, M. [1 ]
Eppenberger-Castori, S. [1 ]
Matter, M. S. [1 ]
Zellweger, N. [2 ]
Rothschild, S. I. [2 ]
Bubendorf, L. [1 ]
机构
[1] Univ Hosp Basel, Inst Med Genet & Pathol, Pathol, Basel, Switzerland
[2] Univ Hosp Basel, Dept Oncol, Basel, Switzerland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4P
引用
收藏
页码:S700 / S700
页数:1
相关论文
共 50 条
  • [31] Clinicopathologic Characteristics of Non-Small Cell Lung Carcinomas Harboring MET Exon 14 Skipping Mutations
    Fujii, T.
    Uruga, H.
    Nakamura, N.
    Kohno, T.
    Kishi, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2254 - S2255
  • [32] Antitumor effects of ensartinib in non-small cell lung cancer harboring MET exon 14-skipping mutations
    Xia, Yang
    Lan, Fen
    Zhao, Jing
    Shen, Hua-Hao
    Selvaggi, Giovanni
    Li, Wen
    CANCER RESEARCH, 2022, 82 (12)
  • [33] Non-small cell lung cancer with MET exon 14 skip mutation: case report
    Clough, Wolfgang
    Al Jaberi, Mira
    Dalia, Samir
    ANNALS OF TRANSLATIONAL MEDICINE, 2022,
  • [34] Intertumoral Molecular Heterogeneity of Non-small Cell Lung Cancer with MET Exon 14 Skipping
    Han, Y.
    Chen, S.
    Xiang, C.
    Guo, L.
    Zhu, L.
    Shao, J.
    Hu, T.
    Wang, J.
    Zhu, C.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S60 - S61
  • [35] Identification of a Novel MET Exon 14 Skipping Variant in Non-Small Cell Lung Cancer
    Cheng, Y.
    Das, R.
    Jakubowski, M.
    Spildener, J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S89 - S89
  • [36] MET exon 14 Variants in Non-Small Cell Lung Carcinoma: Prevalence, Clinicopathologic and Molecular Features
    Yuan, Lisi
    Bosler, David
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1831 - 1832
  • [37] MET Exon 14 Variants in Non-Small Cell Lung Carcinoma: Prevalence, Clinicopathologic and Molecular Features
    Yuan, Lisi
    Mehrotra, Harshita
    He, Xin
    Bosler, David
    JOURNAL OF MOLECULAR PATHOLOGY, 2023, 4 (01): : 46 - 56
  • [38] MET exon 14 Variants in Non-Small Cell Lung Carcinoma: Prevalence, Clinicopathologic and Molecular Features
    Yuan, Lisi
    Bosler, David
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1831 - 1832
  • [39] Biomarker Testing Patterns and Treatment Outcomes in Patients With Advanced Non-Small Cell Lung Cancer and MET Exon 14 Skipping Mutations
    Kolaei, F. A. Zadeh Vosta
    Cai, B.
    Kanakamedala, H.
    Kim, J.
    Doban, V.
    Zhang, S.
    Shi, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (01) : S16 - S16
  • [40] Clinical characteristics and outcomes of non-small cell lung cancer (NSCLC) patients harboring MET exon 14 splice sites mutations
    Jamme, P.
    Escande, F.
    Descarpentries, C.
    Copin, M. C.
    Dansin, E.
    Vanparis, T.
    Tulasne, D.
    Baldacci, S.
    Kherrouche, Z.
    Cortot, A.
    ANNALS OF ONCOLOGY, 2018, 29